American Century Companies Inc. Has $73.24 Million Position in Encompass Health Corporation $EHC

American Century Companies Inc. increased its stake in Encompass Health Corporation (NYSE:EHC) by 78.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 723,169 shares of the company’s stock after purchasing an additional 318,251 shares during the quarter. American Century Companies Inc. owned approximately 0.72% of Encompass Health worth $73,243,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Colonial Trust Co SC acquired a new position in shares of Encompass Health during the fourth quarter worth approximately $29,000. Transce3nd LLC acquired a new position in shares of Encompass Health during the fourth quarter worth approximately $40,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after purchasing an additional 367 shares during the period. Arlington Trust Co LLC increased its position in shares of Encompass Health by 22.9% during the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after purchasing an additional 125 shares during the period. Finally, Johnson Financial Group Inc. bought a new stake in shares of Encompass Health during the fourth quarter worth $72,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on EHC shares. Wall Street Zen cut Encompass Health from a “strong-buy” rating to a “buy” rating in a report on Friday, June 6th. KeyCorp upped their price target on Encompass Health from $122.00 to $135.00 and gave the company an “overweight” rating in a research note on Tuesday, May 27th. Barclays upped their price target on Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a research note on Friday, April 25th. Royal Bank Of Canada upped their price target on Encompass Health from $110.00 to $125.00 and gave the company an “outperform” rating in a research note on Monday, April 28th. Finally, Truist Financial set a $140.00 price target on Encompass Health and gave the company a “buy” rating in a research note on Thursday, August 14th. Seven investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $134.00.

Encompass Health Stock Performance

Shares of NYSE:EHC opened at $120.26 on Tuesday. The company has a market capitalization of $12.11 billion, a price-to-earnings ratio of 23.53, a P/E/G ratio of 2.10 and a beta of 0.86. The firm’s 50 day simple moving average is $116.13 and its 200 day simple moving average is $109.78. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $123.13.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.20. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health’s revenue for the quarter was up 12.0% on a year-over-year basis. During the same period last year, the company posted $1.11 EPS. As a group, sell-side analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health’s payout ratio is 13.31%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.